📣 VC round data is live. Check it out!

Apyx Medical Valuation Multiples

Discover Apyx Medical's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Edap TMS, Sisram Medical, Inogen, Quanterix and more.

Apyx Medical Overview

About Apyx Medical

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.


Founded

1982

HQ

United States

Employees

220

Financials (LTM)

Revenue: $56M
EBITDA: ($4M)

EV

$170M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Apyx Medical Financials

Apyx Medical reported last 12-month revenue of $56M and negative EBITDA of ($4M).

In the same LTM period, Apyx Medical generated $35M in gross profit, ($4M) in EBITDA losses, and had net loss of ($11M).

Revenue (LTM)


Apyx Medical P&L

In the most recent fiscal year, Apyx Medical reported revenue of $53M and EBITDA of ($4M).

Apyx Medical is unprofitable as of last fiscal year, with gross margin of 63%, EBITDA margin of (7%), and net margin of (21%).

See analyst estimates for Apyx Medical
LTMLast FY202320242025202620272028
Revenue$56M$53M$52M$48M$53M
Gross Profit$35M$33M$34M$29M$33M
Gross Margin62%63%64%61%63%
EBITDA($4M)($4M)($18M)($17M)($5M)
EBITDA Margin(7%)(7%)(35%)(35%)(9%)
EBIT Margin(12%)(12%)(38%)(39%)(12%)
Net Profit($11M)($11M)($19M)($23M)($11M)
Net Margin(21%)(21%)(36%)(49%)(21%)
Net Debt-$3M---

Financial data powered by Morningstar, Inc.

Apyx Medical Stock Performance

Apyx Medical has current market cap of $162M, and enterprise value of $170M.

Market Cap Evolution


Apyx Medical's stock price is $3.86.

Apyx Medical share price decreased by 3.3% in the last 30 days, and increased by 71.8% in the last year.

Apyx Medical has an EPS (earnings per share) of $-0.27.

See more trading valuation data for Apyx Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$170M$162M-2.4%-3.3%4.7%71.8%$-0.27

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Apyx Medical Valuation Multiples

Apyx Medical trades at 3.1x EV/Revenue multiple, and (43.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Apyx Medical

EV / Revenue (LTM)


Apyx Medical Financial Valuation Multiples

As of June 3, 2026, Apyx Medical has market cap of $162M and EV of $170M.

Apyx Medical has a P/E ratio of (14.2x).

LTMLast FY202320242025202620272028
EV/Revenue3.1x3.2x3.3x3.5x3.2x
EV/EBITDA(43.5x)(44.7x)(9.4x)(10.1x)(37.1x)
EV/EBIT(25.7x)(26.5x)(8.5x)(9.0x)(26.4x)
EV/Gross Profit4.9x5.1x5.0x5.8x5.1x
P/E(14.2x)(14.4x)(8.6x)(6.9x)(14.4x)
EV/FCF(16.5x)(19.3x)(29.4x)(9.1x)(18.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Apyx Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Apyx Medical Margins & Growth Rates

Apyx Medical grew revenue by 13% and EBITDA by 7% in the last fiscal year.

In the most recent fiscal year, Apyx Medical reported gross margin of 63%, EBITDA margin of (7%), and net margin of (21%).

See estimated margins and future growth rates for Apyx Medical

Apyx Medical Margins

Last FY202420252026202720282029
Gross Margin63%61%63%62%
EBITDA Margin(7%)(35%)(9%)(7%)
EBIT Margin(12%)(39%)(12%)(12%)
Net Margin(21%)(49%)(21%)(20%)
FCF Margin(17%)(39%)(17%)(21%)

Apyx Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth13%(8%)10%13%
Gross Profit Growth12%(13%)13%12%
EBITDA Growth7%(7%)(73%)(11%)
EBIT Growth7%(6%)(66%)7%
Net Profit Growth4%25%(52%)4%
FCF Growth40%225%(51%)36%

Data powered by FactSet, Inc. and Morningstar, Inc.

Apyx Medical Operational KPIs

Apyx Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Apyx Medical's Rule of 40 is 6% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Apyx Medical's Rule of X is 25% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Apyx Medical
LTMLast FY202320242025202620272028
Rule of 405%6%---
Bessemer Rule of X22%25%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.2M---
G&A Expenses to Revenue-68%93%90%68%
R&D Expenses to Revenue6%6%9%11%6%
Opex to Revenue-75%103%100%75%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Apyx Medical Competitors

Apyx Medical competitors include Edap TMS, Sisram Medical, Inogen, Quanterix, NN, Aroa Biosurgery, EKF Diagnostics, Guerbet, CROSSJECT and Owlet.

Most Apyx Medical public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Edap TMS-2.5x-(7.6x)
Sisram Medical0.4x0.4x2.9x3.5x
Inogen0.2x0.2x26.6x25.1x
Quanterix0.7x0.7x(2.3x)(2.7x)
NN0.9x0.8x7.5x7.1x
Aroa Biosurgery2.8x2.5x81.9x21.4x
EKF Diagnostics2.0x1.9x8.1x7.9x
Guerbet0.5x0.6x5.0x5.0x

This data is available for Pro users. Sign up to see all Apyx Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Apyx Medical

Apyx Medical has acquired 1 company to date.

Last acquisition by Apyx Medical was on October 20th 2015. Apyx Medical acquired Bovie Bulgaria EOOD for $600K (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Apyx Medical

Bovie Bulgaria EOOD
Description
Bovie Bulgaria EOOD is a Sofia-based contract manufacturer and research facility for medical devices. It produces electrosurgical generators, electrodes, and cautery tools under ISO 13485 standards for export to Europe and North America. The company supports parent firm Apyx Medical in assembling handheld plasma devices and precision instruments used in minimally invasive surgeries. Bovie Bulgaria conducts R&D on helium-based ablation technologies, scaling production for operating rooms and outpatient clinics.
HQ CountryBulgaria
HQ City
Sofia
Deal Date20 Oct 2015
Valuation$600K
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Apyx Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Apyx Medical

When was Apyx Medical founded?Apyx Medical was founded in 1982.
Where is Apyx Medical headquartered?Apyx Medical is headquartered in United States.
How many employees does Apyx Medical have?As of today, Apyx Medical has over 220 employees.
Who is the CEO of Apyx Medical?Apyx Medical's CEO is Charles D. Goodwin.
Is Apyx Medical publicly listed?Yes, Apyx Medical is a public company listed on Nasdaq.
What is the stock symbol of Apyx Medical?Apyx Medical trades under APYX ticker.
When did Apyx Medical go public?Apyx Medical went public in 1994.
Who are competitors of Apyx Medical?Apyx Medical main competitors include Edap TMS, Sisram Medical, Inogen, Quanterix, NN, Aroa Biosurgery, EKF Diagnostics, Guerbet, CROSSJECT, Owlet.
What is the current market cap of Apyx Medical?Apyx Medical's current market cap is $162M.
What is the current revenue of Apyx Medical?Apyx Medical's last 12 months revenue is $56M.
What is the current revenue growth of Apyx Medical?Apyx Medical revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Apyx Medical?Current revenue multiple of Apyx Medical is 3.1x.
Is Apyx Medical profitable?No, Apyx Medical is not profitable.
What is the current EBITDA of Apyx Medical?Apyx Medical has negative EBITDA and is not profitable.
What is Apyx Medical's EBITDA margin?Apyx Medical's last 12 months EBITDA margin is (7%).
What is the current EV/EBITDA multiple of Apyx Medical?Current EBITDA multiple of Apyx Medical is (43.5x).
What is the current FCF of Apyx Medical?Apyx Medical's last 12 months FCF is ($10M).
What is Apyx Medical's FCF margin?Apyx Medical's last 12 months FCF margin is (19%).
What is the current EV/FCF multiple of Apyx Medical?Current FCF multiple of Apyx Medical is (16.5x).
How many companies Apyx Medical has acquired to date?As of June 2026, Apyx Medical has acquired 1 company.
What was the largest acquisition by Apyx Medical?$600K acquisition of Bovie Bulgaria EOOD on 20th October 2015 was the largest M&A Apyx Medical has done to date.
What companies Apyx Medical acquired?Apyx Medical acquired Bovie Bulgaria EOOD.
In how many companies Apyx Medical has invested to date?Apyx Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Apyx Medical

Lists including Apyx Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial